1. Home
  2. ATAI vs WNC Comparison

ATAI vs WNC Comparison

Compare ATAI & WNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATAI
  • WNC
  • Stock Information
  • Founded
  • ATAI 2018
  • WNC 1985
  • Country
  • ATAI Germany
  • WNC United States
  • Employees
  • ATAI N/A
  • WNC N/A
  • Industry
  • ATAI Biotechnology: Pharmaceutical Preparations
  • WNC Construction/Ag Equipment/Trucks
  • Sector
  • ATAI Health Care
  • WNC Industrials
  • Exchange
  • ATAI Nasdaq
  • WNC Nasdaq
  • Market Cap
  • ATAI 444.7M
  • WNC 425.6M
  • IPO Year
  • ATAI 2021
  • WNC 1991
  • Fundamental
  • Price
  • ATAI $2.48
  • WNC $10.22
  • Analyst Decision
  • ATAI Strong Buy
  • WNC Hold
  • Analyst Count
  • ATAI 3
  • WNC 1
  • Target Price
  • ATAI $10.50
  • WNC $14.00
  • AVG Volume (30 Days)
  • ATAI 2.7M
  • WNC 613.7K
  • Earning Date
  • ATAI 08-12-2025
  • WNC 07-23-2025
  • Dividend Yield
  • ATAI N/A
  • WNC 3.13%
  • EPS Growth
  • ATAI N/A
  • WNC N/A
  • EPS
  • ATAI N/A
  • WNC N/A
  • Revenue
  • ATAI $1,863,000.00
  • WNC $1,812,354,000.00
  • Revenue This Year
  • ATAI $554.22
  • WNC N/A
  • Revenue Next Year
  • ATAI N/A
  • WNC $18.83
  • P/E Ratio
  • ATAI N/A
  • WNC N/A
  • Revenue Growth
  • ATAI 572.56
  • WNC N/A
  • 52 Week Low
  • ATAI $1.03
  • WNC $6.78
  • 52 Week High
  • ATAI $2.64
  • WNC $24.03
  • Technical
  • Relative Strength Index (RSI)
  • ATAI 66.50
  • WNC 57.29
  • Support Level
  • ATAI $2.06
  • WNC $10.20
  • Resistance Level
  • ATAI $2.55
  • WNC $10.77
  • Average True Range (ATR)
  • ATAI 0.20
  • WNC 0.43
  • MACD
  • ATAI -0.02
  • WNC 0.11
  • Stochastic Oscillator
  • ATAI 72.41
  • WNC 70.82

About ATAI ATAI Life Sciences N.V.

ATAI Life Sciences NV is a clinical-stage biopharmaceutical company on a mission to develop effective mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 (buccal film DMT) for treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder. It is also advancing a drug discovery program to identify novel, non-hallucinogenic 5-HT2AR agonists for TRD.

About WNC Wabash National Corporation

Wabash National Corp operates as the innovation leader of connected solutions for the transportation, logistics, and distribution industries. The company's mission is to enable customers to succeed with breakthrough ideas and solutions that help them move everything from the first to the final mile. It designs and manufactures a diverse variety of products, including dry freight and refrigerated trailers, platform trailers, tank trailers, dry and refrigerated truck bodies, structural composite panels and products, trailer aerodynamic solutions, and specialty food-grade processing equipment.

Share on Social Networks: